 |
The Journal of Neuroscience, July 2, 2008, 28(27):6872-6883; doi:10.1523/JNEUROSCI.1815-08.2008
Previous Article | Next Article 
Neurobiology of Disease
Type III Neuregulin-1 Is Required for Normal Sensorimotor Gating, Memory-Related Behaviors, and Corticostriatal Circuit Components
Ying-Jiun J. Chen,1
Madeleine A. Johnson,2
Michael D. Lieberman,3
Rose E. Goodchild,4
Scott Schobel,8
Nicole Lewandowski,3
Gorazd Rosoklija,8,9
Ruei-Che Liu,7
Jay A. Gingrich,8
Scott Small,4
Holly Moore,8
Andrew J. Dwork,1,8,9
David A. Talmage,5,6 and
Lorna W. Role1,2,3,5
1Department of Cell Biology and Pathology, 2Center for Neurobiology and Behavior, 3Integrated Program in Cellular, Molecular, and Biophysical Studies, 4Department of Neurology, 5Institute of Human Nutrition, 6Department of Pediatrics, College of Physicians and Surgeons, and 7Department of Biostatistics, School of Pubic Health, Columbia University, and 8Departments of Psychiatry and 9Neuroscience, New York State Psychiatric Institute, New York, New York 10032
Correspondence should be addressed to either of the following: Dr. David A. Talmage at his present address: Department of Pharmacology and Center for Brain and Spinal Cord Research, Stony Brook University, Stony Brook, NY 11794-5230, Email: david.talmage{at}stonybrook.edu; or Dr. Lorna W. Role at her present address: Center for Brain and Spinal Cord Research, Stony Brook University, Stony Brook, NY 11794-5230, Email: lorna.role{at}stonybrook.edu
Neuregulin-1 (Nrg1)/erbB signaling regulates neuronal development, migration, myelination, and synaptic maintenance. The Nrg1 gene is a schizophrenia susceptibility gene. To understand the contribution of Nrg1 signaling to adult brain structure and behaviors, we studied the regulation of type III Nrg1 expression and evaluated the effect of decreased expression of the type III Nrg1 isoforms. Type III Nrg1 is transcribed by a promoter distinct from those for other Nrg1 isoforms and, in the adult brain, is expressed in the medial prefrontal cortex, ventral hippocampus, and ventral subiculum, regions involved in the regulation of sensorimotor gating and short-term memory. Adult heterozygous mutant mice with a targeted disruption for type III Nrg1 (Nrg1tm1.1Lwr+/–) have enlarged lateral ventricles and decreased dendritic spine density on subicular pyramidal neurons. Magnetic resonance imaging of type III Nrg1 heterozygous mice revealed hypofunction in the medial prefrontal cortex and the hippocampal CA1 and subiculum regions. Type III Nrg1 heterozygous mice also have impaired performance on delayed alternation memory tasks, and deficits in prepulse inhibition (PPI). Chronic nicotine treatment eliminated differences in PPI between type III Nrg1 heterozygous mice and their wild-type littermates. Our findings demonstrate a role of type III Nrg1 signaling in the maintenance of corticostriatal components and in the neural circuits involved in sensorimotor gating and short-term memory.
Key words: lateral ventricle; dendritic spine; cerebral blood volume; memory; prepulse inhibition; schizophrenia
Received June 26, 2007;
accepted May 7, 2008.
Correspondence should be addressed to either of the following: Dr. David A. Talmage at his present address: Department of Pharmacology and Center for Brain and Spinal Cord Research, Stony Brook University, Stony Brook, NY 11794-5230, Email: david.talmage{at}stonybrook.edu; or Dr. Lorna W. Role at her present address: Center for Brain and Spinal Cord Research, Stony Brook University, Stony Brook, NY 11794-5230, Email: lorna.role{at}stonybrook.edu
This article has been cited by other articles:

|
 |

|
 |
 
C. M. P. O'Tuathaigh, B. P. Kirby, P. M. Moran, and J. L. Waddington
Mutant Mouse Models: Genotype-Phenotype Relationships to Negative Symptoms in Schizophrenia
Schizophr Bull,
November 24, 2009;
(2009)
sbp125v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Jaaro-Peled, Y. Ayhan, M. V. Pletnikov, and A. Sawa
Review of Pathological Hallmarks of Schizophrenia: Comparison of Genetic Models With Patients and Nongenetic Models
Schizophr Bull,
November 10, 2009;
(2009)
sbp133v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. van den Buuse
Modeling the Positive Symptoms of Schizophrenia in Genetically Modified Mice: Pharmacology and Methodology Aspects
Schizophr Bull,
November 9, 2009;
(2009)
sbp132v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Vullhorst, J. Neddens, I. Karavanova, L. Tricoire, R. S. Petralia, C. J. McBain, and A. Buonanno
Selective Expression of ErbB4 in Interneurons, But Not Pyramidal Cells, of the Rodent Hippocampus
J. Neurosci.,
September 30, 2009;
29(39):
12255 - 12264.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Schobel, N. M. Lewandowski, C. M. Corcoran, H. Moore, T. Brown, D. Malaspina, and S. A. Small
Differential Targeting of the CA1 Subfield of the Hippocampal Formation by Schizophrenia and Related Psychotic Disorders
Arch Gen Psychiatry,
September 1, 2009;
66(9):
938 - 946.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Keri, I. Seres, O. Kelemen, and G. Benedek
The Relationship Among Neuregulin 1-Stimulated Phosphorylation of AKT, Psychosis Proneness, and Habituation of Arousal in Nonclinical Individuals
Schizophr Bull,
June 23, 2009;
(2009)
sbp063v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|